TMS-Cobot has been approved in Australia by TGA. Intended purpose : Robotic systems intended to automate and improve the accuracy and repeatability of the positioning of a Transcranial Magnetic Stimulation (TMS) coil, in the clinical situations where compatible TMS devices are intended to be used, with the exception of peripheral nerve stimulation.
Robotics contribution is highlighted in new Expert Guidelines for safety and recommendation for TMS use : Reliability, accuracy, repeatability of coil positioning, coil contact, reduced human interactions in the current pandemic context, reduced human bias, reduced exposure to electromagnetic fields. Importance to meet electrical safety and electromagnetic compatibility standards. Reference: Safety and recommendations for TMS…
A new article published in the Brain Stimulation journal, entitled “Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic” highlights the advantage of robotics in TMS administration during the COVID-19 pandemic: “Robotic TMS provides some opportunity for TMS administration with operators further removed from participants (easily by 2 m/6 feet except for brief…
Visit the MagVenture booth to see demonstrations with TMS-Cobot.
Visit our booth #411 to see demonstrations with TMS-Cobot.
Visit Axilum Robotics’s booth at the 3rd European Conference on Brainstimulation in Psychiatry, Oct. 18-20 2018, Lyon, France.
Visit our booth #1027 at the US Psych Congress, Oct. 25-28, Orlando, FL, USA.
Axilum Robotics supports the Non-Invasive Brain Stimulation Winter School at Danish Research Centre for Magnetic Resonance, in Copenhagen, 27-30 November 2018.
Axilum Robotics presents its new robotic platform at Viva Technology meeting in Paris, May 24-26 2018, on France Biotech Medtech hub. See France Biotech press release
Axilum Robotics at 2nd European Conference on Brain Stimulation in Psychiatry – Munich – Oct 12-14, 2017